- What is Quanta, Inc.'s stock symbol?
Our stock is traded on the OTCQB under the symbol QNTA.
- When was Quanta, Inc. incorporated?
April 28, 2016
- When did Quanta, Inc. become a public company?
January 17, 2018
- Where is Quanta, Inc. located?
632 S Glenwood Pl.
Burbank, CA 91405
- When is Quanta, Inc.'s fiscal year end?
- Who is Quanta, Inc.'s transfer agent?
Action Stock Transfer Corporation
2469 E. Fort Union Blvd
Salt Lake City, UT 84121
- Who is Quanta, Inc.'s independent auditor?
Weinberg & Company
1925 Century Park E.
Los Angeles, CA 90067
- Who is Quanta, Inc.'s outside legal counsel?
New Venture Attorneys, P.C.
101 Church Street
Los Gatos, California 95030
T: +1 408-560-9606
F: +1 408-583-4180
- Is Quanta, Inc. a cannabis company?
No. Quanta is not a cannabis company. We are an applied science company focused on increasing energy levels in plant matter to increase performance within the human body. Our proprietary technology uses quantum mechanics to increase bio-activity of targeted molecules to enhance the desired effects. We specialize in potentiating rare naturally occurring elements to create impactful and sustainable healing solutions that we believe will one day be as powerful and predictable as pharmaceutical drugs. Most simply stated, our technology “polarizes” any plant-based matter and makes it incredibly potent. We launched our company with polarized CBD, to achieve proof of concept and we’ve now got seven polarized ingredients, which are being used for a variety of consumer healthcare products. Our mission is to power as many impactful, high-performing and wholly organic solutions as possible through our branded product lines and a series of licensing and distribution partnerships.
- Who founded Quanta, Inc. and how did it go public?
The founder of the company is current CEO/Chairman, Eric Rice. The company went public as “Bioanomaly” on June 6, 2018 through a reverse merger with a company called Freight Solutions on June 6, 2018, where Quanta surviving as a wholly-owned subsidiary of the Company. Pursuant to the merger agreement, all the shareholders of Bioanomaly exchanged all of their shares of Bioanomaly for an aggregate of 21,908,810 newly issued shares of Freight Solution’s common stock. Freight Solution shareholders retained 6,500,000 shares of common stock, which represents 23% of the issued and outstanding stock following the merger. Simultaneously with the Merger, the Company accepted subscriptions for 6,500,000 shares of common stock in a private placement offering (the “Offering”) at a purchase price of $0.20 per share, offered pursuant to Regulation D of the Securities Act of 1933, as amended (the “Securities Act”) for the aggregate offering amount of $1,300,000.
- What constitutes Quanta, Inc.’s current product line?
Quanta sells these products today, available on its website, buyquanta.com:
- Quanta Muscle Rub
- Quanta Anti-Aging Cream
- Quanta CBD Drops and Pens
Quanta has launched a new on-line brand with sales expected in 2020 for this product:
- Molequle Anti-Aging Skin Care Cream (available on molequleskincare.com or amazon.com)
Quanta has announced a distribution agreement with RST Sanexas for distribution of its polarized CBD-based muscle rub through its network of doctors, clinicians, and other skin care professionals for their patients/clients.
- What are Quanta, Inc.’s annual sales?
In 2019 Quanta reported annual sales of $1.3 million, which was virtually all attributed to Quanta Muscle Rub. Since then, we’ve announced our first commercial shipment to RST Sanexas, a licensee for our polarized CBD-based muscle rub, and we’ve also shipped hand sanitizer (non-polarized) to a regional wholesale/retail product marketer, who is also offering our full lineup of branded products to their retailers. We have built up our sales and marketing team, and we’ve announced a new brand, molequle that is being marketed as its own brand for on-line retailers, including Amazon. We aren’t giving guidance but we are anticipating a year of growth in 2020 for Quanta.
- Is Quanta, Inc. profitable?
No. Quanta is not yet profitable.